Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.43B
sum of reported positions
Reported positions
590
Changes vs prior quarter
597
102 new · 88 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 459 measured positions in 8 quarters, the typical new or larger position finished −1.5 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 693K | $139M | 1.6% | |
| 1.03M | $126M | 1.5% | |
| 423K | $122M | 1.5% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.98B | $8.43B |
| Positions | 576 | 590 |
| Biggest line | — | NVIDIA 2% |
| 828K |
| $120M |
| 1.4% |
| 206K | $119M | 1.4% |
| 268K | $100M | 1.2% |
| 398K | $95M | 1.1% |
| 314K | $93.4M | 1.1% |
| 204K | $92.9M | 1.1% |
| 216K | $82.2M | 1.0% |
| 1.05M | $78.7M | 0.9% |
| 182K | $77.2M | 0.9% |
| 1.45M | $69.3M | 0.8% |
| 192K | $68M | 0.8% |
| 531K | $63.6M | 0.8% |
| 99K | $63.6M | 0.8% |
| 701K | $63.3M | 0.8% |
| 161K | $60.7M | 0.7% |
| 394K | $60.3M | 0.7% |
| 1.16M | $59.9M | 0.7% |
| 499K | $58.5M | 0.7% |
| 584K | $58.3M | 0.7% |
| 360K | $57.7M | 0.7% |
| 796K | $57.6M | 0.7% |
| 3.09M | $57.5M | 0.7% |
Supernus Pharmaceuticals, Inc. (SUPN)
23K → 26K shares (+12%)
WISDOMTREE TR YIELD ENHANCD US
29K → 28K shares (−4%)
Astrana Health, Inc. (ASTH)
26K shares
Pangaea Logistics Solutions (PANL)
184K shares
Omnicell (OMCL)
27K shares
Perrigo (PRGO)
107K shares
Teradata (TDC)
32K shares
Collegium Pharmaceutical, Inc. (COLL)
22K → 30K shares (+35%)
Innoviva, Inc. (INVA)
40K → 46K shares (+14%)
Ionq (IONQ)
19K shares
Ring Energy (REI)
937K shares
Northeast Community Bancorp, Inc. (NECB)
99K → 36K shares (−63%)
THERAVANCE BIOPHARMA INC
56K shares
Kinder Morgan (KMI)
86K → 28K shares (−68%)
Pacira BioSciences, Inc. (PCRX)
30K → 35K shares (+18%)
Liberty Capital Corp (GLIBA)
37K shares
Emergent Biosolutions (EBS)
106K → 95K shares (−10%)
Immersion (IMMR)
422K → 114K shares (−73%)
HNI Corporation (HNI)
33K → 19K shares (−44%)
Natures Sunshine Products (NATR)
30K shares
Entravision Communications (EVC)
570K → 49K shares (−91%)
Lifetime Brands (LCUT)
61K shares
Grupo Televisa, S.A.B. (TV)
142K → 189K shares (+33%)
INVESCO VARIABLE RATE PREFERRED
19K → 19K shares (+3%)
GLOBAL X FDS US PFD ETF
23K → 24K shares (+4%)
